Cardiovascular Disease

Angiotensin II Receptor Blocker (ARB) for Hypertension

ARBs used for the treatment of hypertension and their respective strengths, formulations, and doses.

Dyslipidemia Drug Indications

Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.

Physical Activity Reduces Risk of Death From Cancer and Cardiovascular Disease

Physical Activity Reduces Risk of Death From Cancer and Cardiovascular Disease

By

In contrast with current guidelines, non-conventional physical activity patterns reduce all-cause, cardiovascular disease (CVD), and cancer mortality.

New Algorithm Adopted by NCCN for Reducing Cardiovascular Disease in Prostate Cancer

New Algorithm Adopted by NCCN for Reducing Cardiovascular Disease in Prostate Cancer

By

Clinicians may need to be more proactive in preventing and treating cardiovascular disease in patients with prostate cancer who are receiving ADT.

Stroke Risk Up Post-Cancer Diagnosis

Stroke Risk Up Post-Cancer Diagnosis

Stroke risk found highest first three months after cancer diagnosis.

QTc Not Prolonged by Onartuzumab Plus Paclitaxel With or Without Bevacizumab

QTc Not Prolonged by Onartuzumab Plus Paclitaxel With or Without Bevacizumab

Onartuzumab with weekly paclitaxel with or without bevacizumab does not prolong the corrected QT (QTc) interval.

Prediagnostic Use of Warfarin No Effect on Mortality for Breast, Colorectal, Lung and Prostate Cancers

Prediagnostic Use of Warfarin No Effect on Mortality for Breast, Colorectal, Lung and Prostate Cancers

Warfarin sodium is an oral anticoagulant that has been shown in pre-clinical studies to inhibit the spread of cancer cells.

Protein Linked to Cancer, Diabetes Also Has Role in Pulmonary Hypertension

Protein Linked to Cancer, Diabetes Also Has Role in Pulmonary Hypertension

The protein Sirtuin3 was linked to the development of pulmonary hypertension.

Exercise Lowers Cardiovascular (CV) Risk in Lymphoma Survivors

Exercise Lowers Cardiovascular (CV) Risk in Lymphoma Survivors

Vigorous exercise may lower cardiovascular risk in adult survivors of childhood Hodgkin's lymphoma.

Coronary Artery Disease Prevalent Among Hodgkin Lymphoma Survivors

Coronary Artery Disease Prevalent Among Hodgkin Lymphoma Survivors

New data show a high prevalence of coronary artery disease among survivors of Hodgkin lymphoma.

Combination Treatments for Hypertension Chart

Hypertension dosing chart for combination antihypertensive medications.

Treatment and Management Goals of Dyslipidemia (Lipids) Chart

Managing dyslipidemia, LDL-C Goals, LDL-C versus Non-HDL-C Goals, and management of low HDL-C.

A Growing Concern Over Increased Cardiovascular Disease Risk in Breast Cancer Survivors

A Growing Concern Over Increased Cardiovascular Disease Risk in Breast Cancer Survivors

By

Patients with breast cancer are living longer after treatment; however, with these therapies comes risk for cardiovascular problems.

Intra-Arterial Therapy Promising for Intrahepatic Chloangiocarcinoma

By

Intra-arterial therapy is associated with promising locoregional control rates among patients with intrahepatic chloangiocarcinoma, according to research presented at SSO 2013.

Diuretics for Hypertension

Hypertension dosing regiment chart for loop, potassium-sparing, and thiazide-like diuretics.

Beta Blockers for Hypertension Pharmacokinetics

Beta-blocker pharmacokinetics comparison chart for hypertension.

Oral Calcium Channel Blockers Chart

Calcium channel blockers (CCB) used to treat hypertension (HTN) including benzothiazepines, dihydropyridines, and diphenylalkylamines.

Angiotensin-Converting Enzyme (ACE) Inhibitors for Hypertension

Angiotensin-Converting Enzyme (ACE) Inhibitors and ACEI Combination Therapy Hypertension Dosing Chart.

Evaluation of Hypertension

BP classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes.

ASH: Dabigatran Reduces Mortality, Intensive Care Stays vs Warfarin

By

Patients treated with dabigatran who experienced major bleeding had a better prognosis than those taking warfarin, investigators reported during the 54th American Society of Hematology Annual Meeting and Exposition.

ENDO: Timing of Vasomotor Symptoms Impacts CVD Risk

ENDO: Timing of Vasomotor Symptoms Impacts CVD Risk

Persistent and late symptoms are linked to one or more cardiovascular disease risk factors.

Cancer Diagnosis Increases Suicide, Cardiovascular Death Risk

Cancer Diagnosis Increases Suicide, Cardiovascular Death Risk

By

Patients had increased risk of suicide and cardiovascular (CV) death following diagnosis of cancer vs. those who were cancer-free.

Vitamin D, Calcium Found to Cut Fracture, Cancer Risk

Vitamin D, Calcium Found to Cut Fracture, Cancer Risk

Vitamin D supplementation can reduce the risk of fracture and cancer; and although there is a biological association between vitamin D deficiency and cardiovascular disease (CVD), there is no evidence that vitamin D supplementation prevents CVD.

Hypertension Treatment Algorithm

Step by step approach to managing hypertension including which anti-hypertensives should be initiated and when to adjust therapy.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs